2021 Cross-Border Healthcare Innovation & Partnership Summit
(MSQ Ventures & Bayhelix)
MSQ Ventures is hosting its 2021 Cross-Border Healthcare Innovation & Partnership Summit, a Virtual event on September 23rd and 24th, together with BayHelix Group. Our partner BayHelix Group is a non-profit organization that connects emerging biopharmaceutical companies in China, with over 800 members globally and over two-thirds of members are C-level executives. The 2-day conference will invite top industry experts to share the most cutting-edge technical information, interpret the latest industrial policies, and fully link the multi-platform of industry, research and investment.
We sincerely invite you to join us in September to participate in this grand event!
Conference Details
Time: 9 am- 12 pm China time (GMT+8), September 23rd and 24th, 2021
Organizers: MSQ Ventures
Co-organizer: BayHelix Group
Meeting Format: Virtual
Register here
Agenda-At-a-Glance
Panel Discussion: China for Global: Out-licensing opportunities, challenges, and perspectives
9:10 am- 10:00 am China time, Sept 23rd (Thursday), 2021
Most Recent Deals:
Aug 9th, 2021: Seagen and RemeGen Announce Exclusive Worldwide License and Co-Development Agreement for Disitamab Vedotin
Aug 17th, 2021: Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China
Feb 1st, 2021: Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 Antibody, Toripalimab, in U.S. and Canada
Dec 16th, 2020: Harbour BioMed Out-Licenses SARS-COV-2 Antibody to AbbVi
Sept 4th, 2020: AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
June 1st, 2020: AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
March 30th, 2020: I-Mab Enters into Strategic Regional Partnership with Kalbe Genexine Biologics for Commercialization Rights of CD73 Antibody, TJD5, for Immuno-Oncology
Jan 13th, 2020: Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada
Panel Discussion: Cross-border Collaboration Opportunites: unmet medical needs and emerging technologies in China
10:00 am- 10:50 am China time, Sept 23rd (Thursday), 2021
Expert Speech: How to monitor pharmaceutical patent listing and generic challenge under China’s patent linkage system
9:05 am - 10:05 am China time, Sept 24th (Friday), 2021
Expert Speech: The latest progress of IND and NDA review procedures in China
10:05 am - 10:35 am China time, Sept 24th (Friday), 2021
Presenting Companies
Here are our last MSQ Roadshow Event (Jan 28th, 2021) highlights & full summary held at our bi-annual event in Shanghai, China: 2021 Cross-Border Healthcare Innovation & Partnership Summit: Insights and Summary